Literature DB >> 15563266

Primary malignant lymphoma arising in the pleura without preceding long-standing pyothorax.

Shinji Hirai1, Yoshiharu Hamanaka, Norimasa Mitsui, Kiyohiko Morifuji, Miwa Sutoh.   

Abstract

We report a very rare case of primary malignant lymphoma arising in the pleura with no history of persistent pyothorax. A 72-year-old male was hospitalized with dyspnea on effort and chest CT demonstrated a mass along the right chest wall. Right thoracotomy with complete en bloc resection of the pleural tumor was performed. Immunohistochemical examination of the pleural tumor showed that the histology was marginal zone B-cell malignant lymphoma. We considered that this tumor had originated from the soft tissue in the chest wall based on radiographical and surgical findings. As diagnosis and treatment of pleural malignant lymphoma seems to have been difficult in most cases reported in the literature, it is thought that early active and accurate biopsy with large-bore needles, or, if possible, surgical incision for early diagnosis and aggressive surgery to achieve complete resection combined with radiation therapy and/or chemotherapy would be very important for a good prognosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15563266

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  10 in total

1.  Primary pleural lymphoma: a rare case and a synopsis of the literature.

Authors:  Xiaohu Ru; Mingjian Ge; Li Li; Yidan Lin; Lunxu Liu
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

2.  Case report. Primary mucosa-associated lymphoid tissue lymphoma as a pleural mass.

Authors:  M L Barahona; V P Dueñas; M T Sánchez; B V Plaza
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

3.  Primary pleural lymphoma: plaque-like thickening of the pleura.

Authors:  Anastasia Oikonomou; Alexandra Giatromanolaki; Dimitrios Margaritis; Marios Froudarakis; Panos Prassopoulos
Journal:  Jpn J Radiol       Date:  2010-01-30       Impact factor: 2.374

Review 4.  Pleuric presentation of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue: a case report and a review of the literature.

Authors:  Giovanna Motta; Concetta Conticello; Gabriella Amato; Gaetano Moschetti; Cristina Colarossi; Sebastiano Cosentino; Massimo Ippolito; Rosario Giustolisi; Francesco Di Raimondo
Journal:  Int J Hematol       Date:  2010-08-20       Impact factor: 2.319

5.  Primary Pleural Extranodal Marginal Zone Lymphoma Presenting as Bilateral Chylothorax.

Authors:  Thushara Paul; Dhiraj Kumar Yadav; Mohamed Alhamar; Vrushali Dabak
Journal:  Case Rep Oncol       Date:  2020-07-30

6.  Primary diffuse large B-cell lymphoma as a chest-wall mass: A case report.

Authors:  Qianwen Zhang; Yuanrong Ju; Tao Qu; Tao Wang; Xiaoqin Liu
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

Review 7.  Surgical treatment in malignant pleural effusion.

Authors:  Şule Karadayı; Ekber Şahin
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2021-10-20       Impact factor: 0.332

8.  Metachronous lesions in the orbit, retroperitoneum, and pleura of mucosa-associated lymphoid tissue lymphoma: A case report.

Authors:  Ayako Shiono; Hisao Imai; Tsugumi Satou; Ryo Taguchi; Naoki Takahashi; Ryuichi Azuma; Ou Yamaguchi; Kosuke Hashimoto; Erika Naito; Hidetoshi Iemura; Yu Miura; Atsuto Mouri; Kyoichi Kaira; Kunihiko Kobayashi; Hiroshi Kagamu
Journal:  Cancer Rep (Hoboken)       Date:  2022-07-28

9.  Slow-growing primary marginal zone B-cell lymphoma arising in the chest wall in a patient without a history of tuberculosis.

Authors:  Ken Ueda; Katsuyuki Nakanishi; Yukihisa Satoh; Mio Sakai; Norifumi Naka; Nobuhito Araki; Yasuhiko Tomita; Noriyuki Tomiyama
Journal:  Acta Radiol Short Rep       Date:  2013-03-18

10.  Rare case of primary pleural lymphoma presenting with pleural effusion.

Authors:  Mei-Ling Sun; Bin Shang; Jian-Hua Gao; Shu-Juan Jiang
Journal:  Thorac Cancer       Date:  2015-03-26       Impact factor: 3.500

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.